Wilmington, United States
Longevity InTime BioTech is pioneering advancements in the health sector with its slogan: "AI Health Online Tracking Technology for prediction & prevention of severe diseases, aimed to prolong life by 20+ years". Established in 2018, the company is headquartered in the United States and operates at the intersection of several industries, including AI, Digital Health, and Life Sciences.
The company has developed a novel clinical trials Ai simulation platform that aims to expedite the approval process for aging treatments, significantly reducing the time and cost involved—achieving results potentially 10x faster and cheaper. Their technology, which employs causal AI, allows for thorough simulation of over 500+ blinded trials, thereby de-risking human trials and aiding in FDA approval.
Key to Longevity InTime's strategic edge are their proprietary methods, currently patent pending with priority positioning in the field. With the backing of their last notable investment—a $100.00K Pre Seed Round from Google Cloud in January 2020—the company is focused on scaling its platform to drive the future of aging treatments.
